Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Miller

Showing results (1-10 of 313) with videos related to

Pageof 32
Sort By:
Urology|June 2, 2009
Editorial comment. The prognosis of the individual patient with prostate has made no quantum leaps during the past 10 yearsKurt Miller
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Hormonal treatment for progressionKurt Miller
Aktuelle Urologie|June 15, 2017
[Review on quality of life in CRPC patients]Kurt Miller
Der Urologe. Ausg. A|December 14, 2020
[The first oral LHRH antagonist-results of the HERO study]Kurt Miller
Aktuelle Urologie|December 7, 2016
Kurt Miller
Aktuelle Urologie|November 30, 2021
Kurt Miller
Aktuelle Urologie|June 3, 2020
[Local therapy for metastasized tumors - paradigm change?]Kurt Miller
Aktuelle Urologie|June 17, 2020
[Sequential therapy for asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer]Kurt Miller
Aktuelle Urologie|May 21, 2021
Kurt Miller
Aktuelle Urologie|May 26, 2023
[Management of metastatic hormone-sensitive prostate cancer - Current treatment options, criteria for progression and switch of therapy]Kurt Miller
Pageof 32

Showing results (1-10 of 313) with videos related to

Sort By:
Pageof 32
Urology|June 2, 2009
Editorial comment. The prognosis of the individual patient with prostate has made no quantum leaps during the past 10 yearsKurt Miller
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Hormonal treatment for progressionKurt Miller
Aktuelle Urologie|June 15, 2017
[Review on quality of life in CRPC patients]Kurt Miller
Der Urologe. Ausg. A|December 14, 2020
[The first oral LHRH antagonist-results of the HERO study]Kurt Miller
Aktuelle Urologie|December 7, 2016
Kurt Miller
Aktuelle Urologie|November 30, 2021
Kurt Miller
Aktuelle Urologie|June 3, 2020
[Local therapy for metastasized tumors - paradigm change?]Kurt Miller
Aktuelle Urologie|June 17, 2020
[Sequential therapy for asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer]Kurt Miller
Aktuelle Urologie|May 21, 2021
Kurt Miller
Aktuelle Urologie|May 26, 2023
[Management of metastatic hormone-sensitive prostate cancer - Current treatment options, criteria for progression and switch of therapy]Kurt Miller
Pageof 32